chr2-189033222-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000393.5(COL5A2):c.*848T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000689 in 152,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00069 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
COL5A2
NM_000393.5 3_prime_UTR
NM_000393.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.128
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-189033222-A-G is Benign according to our data. Variant chr2-189033222-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 333112.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS2
High AC in GnomAd4 at 105 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.*848T>C | 3_prime_UTR_variant | 54/54 | ENST00000374866.9 | NP_000384.2 | ||
COL5A2 | XM_011510573.4 | c.*848T>C | 3_prime_UTR_variant | 57/57 | XP_011508875.1 | |||
COL5A2 | XM_047443251.1 | c.*848T>C | 3_prime_UTR_variant | 59/59 | XP_047299207.1 | |||
COL5A2 | XM_047443252.1 | c.*848T>C | 3_prime_UTR_variant | 58/58 | XP_047299208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866 | c.*848T>C | 3_prime_UTR_variant | 54/54 | 1 | NM_000393.5 | ENSP00000364000.3 | |||
COL5A2 | ENST00000618828 | c.*848T>C | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes AF: 0.000690 AC: 105AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
105
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 428Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 262
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
428
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
262
Gnomad4 EAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000689 AC: 105AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74472
GnomAD4 genome
AF:
AC:
105
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
51
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome type 7A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | COL5A2: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at